Home / Resource Library / Improving outcomes for high-risk DLBCL: a pilot study looking at the role of fractionated cyclophosphamide with RCHOP chemoimmunotherapy (SCUBA-1 trial)

Improving outcomes for high-risk DLBCL: a pilot study looking at the role of fractionated cyclophosphamide with RCHOP chemoimmunotherapy (SCUBA-1 trial)

Membership Organisation

Healthcare Professional

Affected by Lymphoma

Researcher or Advocate

Improving outcomes for high-risk DLBCL: a pilot study looking at the role of fractionated cyclophosphamide with RCHOP chemoimmunotherapy (SCUBA-1 trial)